Polaris Market Research today announced findings from its latest report, projecting the global Virus Filtration Market to grow from USD 4.25 billion in 2023 to USD 13.86 billion by 2032, at a CAGR of 14.1% during 2024–2032. The report profiles 11 leading companies across four market segments, product type, application, end use, and region, with coverage spanning North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Analyst Commentary on Virus Filtration Market Growth
“Demand for biologics, vaccines, and gene and cell therapies is reshaping bioprocessing, and every one of those products must be proven free of viral contaminants, which is powering market growth,” said a Polaris Market Research analyst. “The opportunity lies with suppliers of single-use, high-efficiency filtration instruments and consumables that help biopharmaceutical manufacturers meet stringent regulatory requirements.”
Virus Filtration Market Statistics at a Glance
- 2023 Market Size: USD 4.25 Billion
- 2024 Market Size: USD 4.82 Billion
- 2032 Projected Size: USD 13.86 Billion
- CAGR (2024–2032): 14.1%
- Largest Region: North America
Key Growth Drivers, Major Companies and Segments Covered
Growth Drivers: The rising prevalence of chronic diseases such as cancer, diabetes, and immune system disorders, growing adoption of single-use bioprocessing technologies, and increasing pharmaceutical and biotech research and development investment are the primary forces behind the market’s expansion, alongside growing demand for gene and cell therapies. The report cites cancer estimates of roughly 14.1 million new cases worldwide, projected to reach 21.7 million by 2030, which is fueling demand for therapeutic biologics that require virus filtration. The COVID-19 surge in vaccine and therapeutic demand further highlighted the role of virus filtration in biological drug safety, while stringent regulatory requirements for purity add momentum.
Major Companies Covered: Asahi Kasei Medical, Charles River Laboratories International, Danaher, Clean Cell Inc., GE Healthcare, Lonza Group, Merck KGaA, Sartorius, Qiagen, Thermo Fisher Scientific, and WuXi PharmaTech.
Segments Covered: By Product Type (Consumables, Instruments, Services, Others), By Application (Biologicals, Medical Devices, Air Purification, Water Purification, Others), By End Use (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Medical Device Companies, Contract Research Organizations, Others), By Region.
Segment Insights: The instruments segment is expected to grow fastest as biopharmaceutical companies such as Amgen and Pfizer introduce filtration and chromatography systems for biologics research and production. Biologicals accounted for the highest application revenue share, while medical devices are set to grow at a lucrative rate as manufacturers introduce advanced virus-clearance products. Pharmaceutical and biotechnology companies are expected to hold the largest end-use share, with contract research organizations and academic research institutes contributing meaningful growth through filtration services and virus isolation studies.
??????? ??? ???????? ????????????? ?????? ???? :
https://www.polarismarketresearch.com/industry-analysis/virus-filtration-market
Recent Developments in the Virus Filtration Market
- October 2022: PathoQuest opened a new 7,000-square-foot facility in Wayne, Pennsylvania, and began accepting customers across North America and worldwide for testing of biologics.
- July 2022: Agilitech launched a versatile single-use platform for virus filtration in bioprocessing, designed for highly efficient virus removal.
- July 2022: Pall Corporation collaborated with EverGrain to provide a filtration solution for a new plant-based protein facility in St. Louis, Missouri, using the Pall Membralox Microfiltration System.
Regional Snapshot: North America Leads the Global Market
North America dominates the market and is expected to hold the largest overall share, supported by rising investment and a large base of local pharmaceutical companies, with the United States accounting for the biggest share within the region. Collaborations among regional players, such as the Pall Corporation and EverGrain partnership, are expected to stimulate the growth of advanced filtration products. Europe, Asia Pacific, Latin America, and the Middle East & Africa are also covered in the report, with country-level analysis across more than 20 countries, including the UK, Germany, China, India, Japan, and Brazil.
Why It Matters for Stakeholders Reviewing the Market Forecast 2032
For stakeholders researching the Virus Filtration market forecast 2032 and the top virus filtration companies, the underlying report benchmarks market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2032. It also examines restraints such as intense competition among vendors, and notes that pandemic-era supply chain disruptions caused shortages in some regions. Buyers and investors can use these findings to identify fast-growing product niches, compare leading suppliers, and time their entry into biologics and vaccine manufacturing supply chains.
More Trending Latest Reports By Polaris Market Research:
Human Immunodeficiency Virus (Hiv) Drugs Market
Breathing Easy: The Bronchodilators Market Continues to Grow
Fetal and Neonatal Care Equipment Market
Comments